Get all your news in one place.
100's of premium titles.
One app.
Start reading
Top News
Top News
Health

GSK surpasses Q4 estimates, projects 2024 growth

Illustration shows GSK (GlaxoSmithKline) logo

Pharmaceutical giant GlaxoSmithKline (GSK) has reported better-than-expected fourth-quarter results, exceeding market estimates. The company has also expressed optimism about its growth prospects for the year 2024.

GSK's fourth-quarter revenue reached $11.8 billion, a 1% increase compared to the same period last year. Analysts had estimated a revenue of $11.56 billion, making the actual figures a positive surprise. The growth was mainly driven by strong sales in the company's pharmaceuticals division, which saw a 4% increase in revenue.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.